FIRM FIXED PRICENO SET ASIDE USED.
MACH32 INC - MACH32- DEVELOPMENT OF INTRAMUSCULAR TRANEXAMIC ACID FORMULATION
PIID: 75A50124C00058Solicitation ID: BAA-20-SOL-0002
Signed Date: Oct 9, 2025Effective Date: Sep 27, 2024End Date: Closed on Mar 31, 2026
Key Details
Description
MACH32- DEVELOPMENT OF INTRAMUSCULAR TRANEXAMIC ACID FORMULATION
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.